Covered recipient · General Payments record
MOLLY MOSER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$423.95
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $351.56 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.56 | 22 |
| Exact Sciences Corporation | $36.29 | 2 |
| Acerta Pharma LLC | $34.74 | 2 |
| Novo Nordisk AS | $22.83 | 1 |
| Axsome Therapeutics, Inc. | $17.14 | 1 |
| Lilly USA, LLC | $16.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090648 | CMS |
| ABBVIE INC. | $7.15 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090650 | CMS |
| ABBVIE INC. | $4.69 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090652 | CMS |
| ABBVIE INC. | $4.89 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090654 | CMS |
| ABBVIE INC. | $12.18 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090656 | CMS |
| ABBVIE INC. | $15.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090658 | CMS |
| ABBVIE INC. | $7.33 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090660 | CMS |
| ABBVIE INC. | $17.51 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090662 | CMS |
| ABBVIE INC. | $5.07 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090664 | CMS |
| ABBVIE INC. | $6.85 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090666 | CMS |
| ABBVIE INC. | $3.63 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090668 | CMS |
| ABBVIE INC. | $19.92 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090670 | CMS |
| ABBVIE INC. | $21.88 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090672 | CMS |
| ABBVIE INC. | $7.46 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090674 | CMS |
| ABBVIE INC. | $7.42 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090676 | CMS |
| ABBVIE INC. | $13.86 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090678 | CMS |
| ABBVIE INC. | $9.63 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090680 | CMS |
| ABBVIE INC. | $9.97 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090682 | CMS |
| ABBVIE INC. | $7.64 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090684 | CMS |
| ABBVIE INC. | $7.33 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090686 | CMS |
| ABBVIE INC. | $12.39 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090688 | CMS |
| ABBVIE INC. | $6.30 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107090690 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.71 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105226120 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.03 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105595183 | CMS |
| Axsome Therapeutics, Inc. | $17.14 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148395547 | CMS |
| Exact Sciences Corporation | $20.56 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114653561 | CMS |
| Exact Sciences Corporation | $15.73 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114653567 | CMS |
| Lilly USA, LLC | $16.00 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902978 | CMS |
| Novo Nordisk Inc | $22.83 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100260501 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.